Menopause symptoms are frequently mistaken for thyroid disease, depression, anxiety, ADHD, and other conditions. Learn which diagnoses are most often missed, how to tell them apart, and what guidelines say about getting the right diagnosis and treatment.
Evidence-based caregiver and family resources for metabolic syndrome, including diagnosis criteria, treatment options, lifestyle interventions, and how to support a loved one through dietary, pharmacologic, and monitoring strategies.
Compare metabolic syndrome definitions, ADA and USPSTF screening, AACE and Endocrine Society guidance, and verified diabetes and cardiovascular trial results.
A guide for caregivers and family members supporting someone with NAFLD or MASLD, covering diagnosis, treatment options including resmetirom and GLP-1 receptor agonists, lifestyle interventions, and how to find specialist care.
A guide to safely discontinuing or tapering cardiovascular medications in patients with established CVD, including what is well established, what is plausible but unproven, and when to get urgent care.
A guide to recognizing menopause treatment failure, when to switch therapies, and how society guidelines define inadequate response to HRT and non-hormonal options.
A comprehensive review of the socioeconomic burden of male hypogonadism, including direct medical costs, lost productivity, mental health consequences, and the cost-effectiveness of testosterone replacement therapy.
A deep dive into the emerging mechanisms behind menopause, covering kisspeptin-neurokinin B-dynorphin signaling, neuroinflammation, mitochondrial biology, and what these findings mean for treatment decisions.
A comprehensive clinical history of obesity treatment from early dietary regimens to modern GLP-1 receptor agonists, with primary-source citations and guideline references for patients and clinicians.
A comprehensive clinical history of perimenopause treatment from the 1960s through today, covering hormone therapy, the WHI trial fallout, and current evidence-based guidelines for managing symptoms.
Beyond hot flashes and irregular periods, perimenopause can present as new-onset seizures, auditory changes, autonomic dysfunction, and more. Learn the uncommon signs, their mechanisms, and evidence-based management.
A clinical history of post-surgical recovery care from 19th-century bed rest to modern Enhanced Recovery After Surgery (ERAS) protocols, with an evidence-boundary review of what is well established versus what needs primary-source verification.
A clinical deep-dive into denosumab-associated dermatologic adverse effects, including eczema, cellulitis, alopecia, and rash, with primary-literature citations and practical management guidance.
A clinician-level review of denosumab (Prolia) and its effects on mental health, mood, depression, and neuropsychiatric symptoms. Includes trial data, mechanism analysis, and prescribing guidance.
New clinical research shows weight loss does shift gut microbiome composition, but the relationship is bidirectional and more complex than early studies suggested. Learn what the evidence actually shows, which bacteria matter most, and how this changes clinical practice.
A citation-dense guide to every clinically significant drug-drug interaction with Trulicity (dulaglutide): mechanisms, affected drug classes, management strategies, and the REWIND cardiovascular evidence base.
A guide to dulaglutide (Trulicity) effects on hair and skin, covering clinical trial data, proposed mechanisms, and what patients can expect.
A clinical guide to dulaglutide (Trulicity) seasonal use considerations, covering heat stability, cold-weather injection technique, holiday eating patterns, illness management, and cardiovascular evidence from REWIND.
A clinician-level review of how dulaglutide (Trulicity) affects sexual function in men and women with type 2 diabetes, covering the REWIND trial, hormonal pathways, erectile dysfunction, libido changes, and practical management guidance.
Complete dutasteride dosing guide for adults aged 30-49, covering FDA-approved BPH doses, off-label hair loss use, clinical trial data, and practical management tips for men in their peak working years.
A comprehensive clinical review of how dutasteride (Avodart) affects bone mineral density, fracture risk, and skeletal health in men with BPH and androgenetic alopecia. Includes trial data, mechanisms, and monitoring guidance.
Complete guide to dutasteride (Avodart) storage conditions, shelf-life data, chemical stability, and what happens when capsules are exposed to heat, moisture, or light, with PubMed and FDA citations.
What stopping Jardiance may change, how heart failure and kidney evidence differ, and what to record for a personal stopping discussion.
A analysis of how enclomiphene citrate affects cognitive function, mood, and brain health in men with secondary hypogonadism, including clinical trial data, proposed mechanisms, and dosing context.
A clinician-level review of how enclomiphene citrate affects bone mineral density, estradiol signaling, and fracture risk in men with secondary hypogonadism, with primary-literature citations throughout.
A clinical deep-dive into how enclomiphene citrate affects mood, cognition, and mental health in men with secondary hypogonadism, with primary-literature citations and practical prescribing guidance.
Step-by-step epitalon self-injection technique, mechanism of action, dosing protocols, and safety considerations. Written by the HealthRX.com medical team and backed by primary research.
How to store epitalon tetrapeptide correctly, what affects its shelf life, and the biochemical reasons why temperature, light, and reconstitution method matter. prepared by the HealthRX.com Editorial Team.
A comparison of compounded and branded oral estradiol for menopausal HRT, covering bioequivalence, safety, cost, FDA regulation, and how to choose the right formulation for your patient.
A clinician-level comparison of oral estradiol cost against patch, gel, spray, vaginal, and compounded estrogen options, with dosing, pharmacokinetics, and real-world pricing data.
A guide to oral estradiol for menopause covering FDA approval, dosing, clinical trial evidence, side effects, and when to consider alternatives.
A clinician-level review of emerging oral estradiol formulations, novel delivery mechanisms, and pipeline candidates advancing beyond standard estradiol tablets for menopausal hormone therapy.
A clinical deep-dive into how oral estradiol is manufactured, where the U.S. Supply chain has fractured, and what shortage events mean for patients on hormone therapy.
A analysis of oral estradiol safety during pregnancy and breastfeeding, covering teratogenicity data, FDA labeling, lactation transfer rates, and clinical decision-making for women of reproductive age.
A guide to discontinuing estradiol transdermal patches, covering tapering schedules, withdrawal symptom management, and the evidence behind different stopping strategies.
How does the estradiol transdermal patch affect sleep architecture? A guide covering REM, slow-wave sleep, sleep efficiency, and clinical trial data for menopausal women.
MD/PharmD-level guide to managing estradiol transdermal patches across time zones, long-haul flights, heat exposure, and irregular schedules. Includes change-day math, missed-dose rules, and storage limits.
A clinical deep-dive into AndroGel (testosterone gel) dosing for Hispanic and Latino patients, covering pharmacogenomics, CYP enzyme variants, insulin resistance, and ethnicity-stratified trial data.
A comprehensive clinical review of dutasteride (Avodart) safety and pharmacogenomic differences in East Asian patients, covering CYP enzyme variation, dosing considerations, and ethnicity-stratified trial data.
A clinical deep-dive into how finasteride performs differently in East Asian men and women, covering pharmacogenomics, ethnicity-stratified trial data, dosing considerations, and what the evidence means for clinical practice.
A clinical review of GHK-Cu copper tripeptide dosing for South Asian patients, covering pharmacogenomics, metabolic risk factors, ethnicity-stratified data, and practical prescribing guidance.
A clinical deep-dive into metformin pharmacogenomics, pharmacokinetics, and outcomes data specific to Black and African ancestry populations, including OCT1/OCT2 variants, renal considerations, and dosing guidance.
A guide to metformin dosing in Hispanic and Latino patients, covering pharmacogenomics, diabetes prevalence, ethnicity-stratified trial data, and practical dose titration protocols.
Evidence-based guide to MK-677 (ibutamoren) dosing for Black and African ancestry patients, covering pharmacogenomics, GH/IGF-1 physiology, hypertension interactions, and CKD risk.
A clinical review of tirzepatide (Mounjaro) efficacy in Black and African ancestry patients, covering SURPASS trial subgroup data, pharmacogenomic factors, hypertension considerations, and evidence-based dosing guidance.
A clinician-facing review of how Hispanic / Latino ancestry affects the safety, pharmacogenomics, and dosing of oral micronized progesterone (Prometrium), covering CYP2C19 variants, diabetes risk, and ethnicity-stratified trial data.
A clinical deep-dive into how spironolactone's safety profile differs for South Asian patients, covering pharmacogenomics, cardiovascular risk, dosing considerations, and monitoring protocols backed by primary evidence.
Semaglutide 2.4 mg (Wegovy) produces smaller absolute weight-loss percentages in East Asian trial cohorts than in the predominantly White STEP-1 population, but the metabolic benefit per kilogram lost may be comparable or greater. This article separates what STEP-6 actually showed from what remains extrapolated.
A guide to how semaglutide 2.4 mg (Wegovy) performs in South Asian patients, covering ethnicity-specific BMI thresholds, pharmacogenomics, GI tolerability, cardiovascular risk, and dosing considerations backed by trial subgroup data.
A physician-level review of evolocumab (Repatha) and liver function: ALT/AST patterns, hepatotoxicity risk, monitoring requirements, and what FOURIER and post-marketing data tell clinicians managing patients on PCSK9 inhibitor therapy.
Everything clinicians and patients need to know about evolocumab (Repatha) storage requirements, shelf life, cold-chain management, and what to do when the product is exposed to adverse conditions.
Ezetimibe alone raises ALT or AST above 3x ULN in about 0.4% of patients, rising to 1.3% with a statin. These elevations are reversible and usually silent.
A clinician-level review of how finasteride is made, which manufacturers supply it, what caused past shortages, and what patients and prescribers should know about supply risks today.
A state-by-state guide to Medicaid coverage of finasteride for male pattern hair loss and BPH, including prior authorization criteria, step therapy requirements, appeal strategies, and cash-pay alternatives.
A comprehensive guide to finasteride's mechanism of action, patent expiration, generic availability, and clinical evidence for AGA and BPH.
A guide to flibanserin (Addyi) safety in women aged 65 and older, covering falls risk, drug interactions, renal function, and deprescribing considerations backed by clinical evidence.
Complete guide to flibanserin (Addyi) storage conditions, shelf life, stability data, and mechanism of action. with FDA and PubMed citations.
A guide to GLP-1 receptor agonists: mechanism of action, approved drugs, clinical trial results, side effects, dosing, and how to choose the right therapy.
A deep-dive into the SURMOUNT-3 trial results, how tirzepatide compares across the full SURMOUNT and STEP trial programs, and what the data means for patients considering GLP-1 or GIP/GLP-1 therapy today.
A detailed breakdown of SURMOUNT-4 and the full SURMOUNT and STEP trial programs. Learn what stopping tirzepatide or semaglutide actually does to body weight, and what the clinical evidence says about staying on treatment.